P. Gobbi

646 total citations
20 papers, 469 citations indexed

About

P. Gobbi is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Gobbi has authored 20 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Gobbi's work include Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). P. Gobbi is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). P. Gobbi collaborates with scholars based in Italy and United States. P. Gobbi's co-authors include S Tura, Pier Luigi Zinzani, Carla Pieresca, Ercole Brusamolino, E Ascari, Giovanni Grignani, Mauro Fiacchini, Massimo Federico, Silvia Brugnatelli and Monia Marchetti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

P. Gobbi

20 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Gobbi Italy 12 329 195 104 99 96 20 469
Delia Rota Scalabrini Italy 11 447 1.4× 290 1.5× 188 1.8× 134 1.4× 97 1.0× 25 600
Judith Huerta‐Guzmán Mexico 17 400 1.2× 400 2.1× 116 1.1× 96 1.0× 97 1.0× 42 666
Simone Snijder Netherlands 13 396 1.2× 236 1.2× 178 1.7× 76 0.8× 82 0.9× 25 625
Carla Pieresca Italy 11 362 1.1× 188 1.0× 80 0.8× 131 1.3× 148 1.5× 23 489
José C. Díaz‐Maqueo Mexico 12 261 0.8× 294 1.5× 89 0.9× 52 0.5× 72 0.8× 34 529
M. Crump Canada 9 187 0.6× 177 0.9× 121 1.2× 121 1.2× 48 0.5× 20 462
J H Glick United States 13 249 0.8× 288 1.5× 67 0.6× 85 0.9× 130 1.4× 23 623
Barbara Vannata Italy 12 347 1.1× 237 1.2× 60 0.6× 72 0.7× 136 1.4× 23 584
Ferial Shihadeh United States 10 329 1.0× 255 1.3× 207 2.0× 124 1.3× 98 1.0× 17 576
L Babini Italy 13 253 0.8× 135 0.7× 149 1.4× 168 1.7× 82 0.9× 33 464

Countries citing papers authored by P. Gobbi

Since Specialization
Citations

This map shows the geographic impact of P. Gobbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Gobbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Gobbi more than expected).

Fields of papers citing papers by P. Gobbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Gobbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Gobbi. The network helps show where P. Gobbi may publish in the future.

Co-authorship network of co-authors of P. Gobbi

This figure shows the co-authorship network connecting the top 25 collaborators of P. Gobbi. A scholar is included among the top collaborators of P. Gobbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Gobbi. P. Gobbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gobbi, P., Francesco Valentino, Paola Lambelet, et al.. (2009). Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. Bone Marrow Transplantation. 44(1). 19–25. 3 indexed citations
3.
Sacchi, Stefano, Luigi Marcheselli, Alessia Bari, et al.. (2008). Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study. Haematologica. 93(9). 1335–1342. 29 indexed citations
4.
Gobbi, P., Franco Corbella, Francesco Valentino, et al.. (2008). Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. Annals of Oncology. 20(3). 465–468. 20 indexed citations
6.
Pavone, Vincenzo, Umberto Ricardi, Stefano Luminari, et al.. (2008). ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. Annals of Oncology. 19(4). 763–768. 7 indexed citations
7.
Federico, Massimo, Cesare Guglielmi, Stefano Luminari, et al.. (2007). Prognostic relevance of serum  2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. Haematologica. 92(11). 1482–1488. 33 indexed citations
8.
Gobbi, P., Francesco Valentino, Maria Chiara Tronconi, et al.. (2007). New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. British Journal of Cancer. 98(2). 328–334. 19 indexed citations
9.
Gobbi, P., Chiara Broglia, Francesco Valentino, et al.. (2006). The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL). Annals of Oncology. 17(4). 676–682. 3 indexed citations
10.
Morabito, Fortunato, Caterina Stelitano, Stefano Luminari, et al.. (2005). The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL). Bone Marrow Transplantation. 37(3). 283–288. 20 indexed citations
12.
Grignani, Giovanni, P. Gobbi, Roberto Formisano, et al.. (1996). A prognostic index for multiple myeloma. British Journal of Cancer. 73(9). 1101–1107. 55 indexed citations
13.
Dionigi, Paolo, et al.. (1995). Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access.. PubMed. 161(2). 137–42. 8 indexed citations
14.
Gobbi, P., Giovanni Grignani, Daniele Bertoloni, et al.. (1994). Primary splenic lymphoma: does it exist?. PubMed. 79(3). 286–93. 35 indexed citations
15.
Tura, S, Mauro Fiacchini, Pier Luigi Zinzani, Ercole Brusamolino, & P. Gobbi. (1993). Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.. Journal of Clinical Oncology. 11(5). 925–930. 63 indexed citations
16.
Gobbi, P., Carla Pieresca, Massimo Federico, et al.. (1993). MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.. Journal of Clinical Oncology. 11(4). 712–719. 25 indexed citations
17.
Riccardi, Alberto, P. Gobbi, Marco Danova, et al.. (1993). MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.. PubMed. 78(1). 44–8. 7 indexed citations
18.
Grignani, Giovanni, P. Gobbi, Daniele Bertoloni, et al.. (1992). Progressive necrotic myelopathy as a paraneoplastic syndrome: report of a case and some pathogenetic considerations. Journal of Internal Medicine. 231(1). 81–85. 6 indexed citations
19.
Gobbi, P., Carla Pieresca, L Ricciardi, et al.. (1990). Night sweats in Hodgkin's disease A manifestation of preceding minor febrile pulses. Cancer. 65(9). 2074–2077. 8 indexed citations
20.
Gobbi, P., A. Crema, Carlomaurizio Montecucco, et al.. (1985). Case report of primary bone lymphoma with disseminated presentation.. PubMed. 70(1). 44–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026